Empowering surgeons. Rewarding innovation. Regenerating lives.

We are LOCATE BIO and we are building a world leading, diversified orthobiologics company that is focused on providing surgeons with a choice of best-in-class products.

Relieving suffering and restoring quality of life with breakthrough products.

LDGraft™ *

Feed the Fusion

LDGraft is an exciting rhBMP-2 product in development, currently in a clinical trial for lumbar interbody fusion procedures.

LDGraft also has an FDA Breakthrough Device designation for the Anterior Lumbar Interbody Fusion (ALIF) indication at one level from L3-S1 for patients with degenerative disc disease.

* For investigational use only, not approved for sale

Who we are

LOCATE BIO is an innovative UK MedTech company with industry-leading drug delivery and tissue scaffold capabilities.


Developing next-generation solutions that address unmet musculoskeletal needs


Unleashing and realising potential within a fearless organisation


Develop next-generation products capable of dominating each of their market segments